Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

VentriPoint Diagnostics Ltd. (V:VPT)

Business Focus: Advanced Medical Equipment & Technology

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for VPT within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 13, 2021 03:01 ET
Ventripoint Issues Option Grants
Toronto, Ontario – TheNewswire - January 13, 2021 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”), (TSXV:VPT) & (OTC:VPTDF) announces the granting 100,000 options to each of the Directors of the Corporation at an exercise price of $0.10 for a term of 10 years with 25% vesting immediately and 25% vesting each year for 3 years thereafter. In addition, 1,410,000 option have been granted to employees and consultants at an exercise price of $0.10 for term from 1 to 10 years, with variable vesting schedules. The Corporation now has 1,542,435 options available for future gran
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
0.04
--
--
Price to Sales - TTM
273.08
25.37
12.51
Price to Book - most recent quarter
--
4.08
4.00
Price to Cash Flow per share - TTM
--
39.19
16.26
Price to Free Cash Flow per share - TTM
--
35.04
27.60
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 2020233-8,502
Dec 15, 20208,735-761,111
Nov 30, 2020769,846744,846
See Short Report

Business Summary

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology

Ventripoint Diagnostics Ltd., formerly Luca Capital Inc., is a medical device company. The Company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates accurate heart volumetric measurements and a three-dimensional (3D) model in a rapid and inexpensive manner. The Company's solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating Knowledge Based Reconstruction (KBR) algorithms and cardiac databases (catalogues). Its technology platform is applicable to all heart diseases. The Company has developed prototype analytical software package to be used with 4D echocardiograms (VMS-4DE) and one to be used with magnetic resonance imaging (MRI) images (VMS-CMR). It also focuses on developing VMS-Plus and the VMS-Nano.

See business summary

 

Twitter

Search (past week) for $VPT.CA VPT.V